EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Development of a Long-Acting Follicle-Stimulating Hormone Using Serum Albumin Fab-Associated Technology for Female Infertility

Daham Kim, Yoon Hee Cho, Min Jeong Kang, So Jeong Lee, Soohyun Lee, Bo Hyon Yun, Hyunjin Chi, Jeongsuk An, Kyungsun Lee, Jaekyu Han, Susan Chi, Moo Young Song und 2 weitere

Endocrinology and Metabolism · 2025

DOI: 10.3803/enm.2024.2090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology and Metabolism, 2025. Verfasst von Daham Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Infertility, Female, Follicle Stimulating Hormone, Serum Albumin. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIEHS NIH HHS, Ministry of Health and Welfare, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recombinant human follicle-stimulating hormone (rhFSH) is commonly used to treat female infertility, but its short half-life necessitates multiple doses. Even corifollitropin alfa, with an extended half-life, requires supplementary injections of rhFSH after 7 days. This study aimed to develop and evaluate a long-acting follicle-stimulating hormone (FSH) formulation using anti-serum albumin Fab-associated (SAFA) technology to avoid additional injections and enhance ovarian function.

Methods

SAFA-FSH was synthesized using a Chinese hamster ovary expression system. Its biological efficacy was confirmed through assays measuring its ability to stimulate cyclic adenosine monophosphate (cAMP) production, estradiol synthesis, and the expression of human cytochrome P450 family 19 subfamily A member 1 (hCYP19α1) and human steroidogenic acute regulatory protein (hSTAR) in human ovarian granulosa (KGN) cells. To evaluate the effects of SAFA-FSH, we compared its impact on serum estradiol levels and ovarian weight increase with that of rhFSH in Sprague-Dawley (SD) rats using the modified Steelman-Pohley test.

Results

The results indicated that SAFA-FSH induces cAMP synthesis in KGN cells and upregulates the expression of hCYP19α1 and hSTAR in a dose-dependent manner. Female SD rats, aged 21 days, receiving daily subcutaneous human chorionic gonadotropin injections for 5 days exhibited a significant increase in serum estradiol levels and ovarian weight when administered SAFA-FSH on the first day or when given nine injections of rhFSH over 5 days. Notably, the group receiving SAFA-FSH on the first and third days demonstrated an even greater rise in serum estradiol levels and ovarian weight.

Conclusion

These findings suggest that SAFA-FSH presents a promising alternative to current rhFSH treatments for female infertility. However, further research is essential to thoroughly assess its safety and efficacy in clinical contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infertility, FemaleFollicle Stimulating HormoneSerum AlbuminFemaleAnimalsHumansRatsRats, Sprague-DawleyCricetulusCHO CellsCricetinaeEstradiolRecombinant ProteinsOvarySteroidogenic Acute Regulatory ProteinCyclic AMP

Stichwörter der Autor:innen

Female infertilityFollicle stimulating hormoneGonadotropinsOvulation

Substanzen

Follicle Stimulating HormoneSerum AlbuminEstradiolRecombinant ProteinsSteroidogenic Acute Regulatory ProteinCyclic AMP

Autor:innen und Institutionen

  • Department of Internal Medicine, Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Tropical Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea.
  • AprilBio Co. Ltd., Kangwon National University, Chuncheon, Korea.

Förderung

  • NIEHS NIH HHS
  • Ministry of Health and Welfare
  • Korea Health Industry Development Institute

Zitieren

APA

Kim, D., Cho, Y. H., Kang, M. J., Lee, S. J., Lee, S., Yun, B. H., Chi, H., An, J., Lee, K., Han, J., Chi, S., Song, M. Y., Cha, S. H., & Lee, E. J. (2025). Development of a Long-Acting Follicle-Stimulating Hormone Using Serum Albumin Fab-Associated Technology for Female Infertility. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2024.2090

Vancouver

Kim D, Cho YH, Kang MJ, Lee SJ, Lee S, Yun BH, et al. Development of a Long-Acting Follicle-Stimulating Hormone Using Serum Albumin Fab-Associated Technology for Female Infertility. Endocrinology and Metabolism. 2025. doi:10.3803/enm.2024.2090

BibTeX
@article{Kim2025,
  author = {Kim, Daham and Cho, Yoon Hee and Kang, Min Jeong and Lee, So Jeong and Lee, Soohyun and Yun, Bo Hyon and Chi, Hyunjin and An, Jeongsuk and Lee, Kyungsun and Han, Jaekyu and Chi, Susan and Song, Moo Young and Cha, Sang-Hoon and Lee, Eun Jig},
  title = {Development of a Long-Acting Follicle-Stimulating Hormone Using Serum Albumin Fab-Associated Technology for Female Infertility},
  journal = {Endocrinology and Metabolism},
  year = {2025},
  doi = {10.3803/enm.2024.2090}
}
Kostenlos starten →